IMMUNIC, INC. (IMUX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch IMUX
See up to 3 months of IMUX. The 7-day demo opens the 1M and 3M ranges and puts IMUX on your watchlist.
Start 7-day demoLatest IMUX insider trades
Daniel Vitt - OfficerOpen-market purchase$12K- Duane Nash - OfficerOpen-market purchase$17K
- Joerg Neermann - Director
About IMMUNIC, INC. (IMUX)
IMMUNIC, INC. is an SEC registrant, filing under CIK 0001280776, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
IMUX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 101,480 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IMUX insider transactions (Form 4)
5246 Form 4 filings on record, the earliest from Nov 13, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert Thorvald Nagel - Director | Grant or award | Stock Option | 25,370 | $0.00 | - | |
| BVF PARTNERS L P - Director | Grant or award | Stock Option | 25,370 | $0.00 | - | |
| Elena Ridloff - Director | Grant or award | Stock Option | 50,740 | $0.00 | - | |
| Simona Skerjanec - Director | Grant or award | Stock Option | 25,370 | $0.00 | - | |
| Richard Alan Rudick - Director | Grant or award | Stock Option | 25,370 | $0.00 | - | |
| Barclay A. Phillips - Director | Grant or award | Stock Option | 25,370 | $0.00 | - | |
| Joerg Neermann - Director | Grant or award | Stock Option | 25,370 | $0.00 | - | |
 Jon Congleton - Director | Grant or award | Stock Option | 25,370 | $0.00 | - | |
| Jon Congleton - Director | Grant or award | Stock Option | 50,740 footnote F1 | $0.00 | - | |
| ||||||
| Simona Skerjanec - Director | Grant or award | Stock Option | 25,370 footnote F1 | $0.00 | - | |
| ||||||
| Richard Alan Rudick - Director | Grant or award | Stock Option | 25,370 footnote F1 | $0.00 | - | |
| ||||||
| Tamar D. Howson - Director | Grant or award | Stock Option | 25,370 footnote F1 | $0.00 | - | |
| ||||||
| Joerg Neermann - Director | Grant or award | Stock Option | 25,370 footnote F1 | $0.00 | - | |
| ||||||
| Barclay A. Phillips - Director | Grant or award | Stock Option | 25,370 footnote F1 | $0.00 | - | |
| ||||||
| Jason Tardio - Officer | Grant or award | Stock Option | 253,000 footnote F1 | $0.00 | - | |
| ||||||
 Glenn Whaley - Officer | Grant or award | Stock Option | 120,000 footnote F1 | $0.00 | - | |
| ||||||
| Daniel Vitt - Director | Grant or award | Stock Option | 445,000 footnote F1 | $0.00 | - | |
| ||||||
| Michael W. Bonney - Director | Grant or award | Stock Option | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| Erik Lundgren - Officer | Grant or award | Stock Option | 1,000,000 | $0.00 | - | |
| Michael A. Panzara - Officer | Grant or award | Stock Option | 300,000 | $0.00 | - | |
| Glenn Whaley - Officer | Grant or award | Stock Appreciation Right | 280,000 | $0.00 | - | |
| Glenn Whaley - Officer | Grant or award | Stock Appreciation Right | 560,000 | $0.00 | - | |
| Glenn Whaley - Officer | Grant or award | Stock Appreciation Right | 560,000 | $0.00 | - | |
| Glenn Whaley - Officer | Grant or award | Stock Appreciation Right | 280,000 | $0.00 | - | |
| Glenn Whaley - Officer | Grant or award | Stock Appreciation Right | 280,000 | $0.00 | - | |
| Duane Nash - Officer | Grant or award | Stock Appreciation Right | 315,000 | $0.00 | - | |
| Duane Nash - Officer | Grant or award | Stock Appreciation Right | 630,000 | $0.00 | - | |
| Duane Nash - Officer | Grant or award | Stock Appreciation Right | 630,000 | $0.00 | - | |
| Duane Nash - Officer | Grant or award | Stock Appreciation Right | 315,000 | $0.00 | - | |
| Duane Nash - Officer | Grant or award | Stock Appreciation Right | 315,000 | $0.00 | - | |
| Daniel Vitt - Officer | Grant or award | Stock Appreciation Right | 860,000 | $0.00 | - | |
| Daniel Vitt - Officer | Grant or award | Stock Appreciation Right | 1,720,000 | $0.00 | - | |
| Daniel Vitt - Officer | Grant or award | Stock Appreciation Right | 1,720,000 | $0.00 | - | |
| Daniel Vitt - Officer | Grant or award | Stock Appreciation Right | 860,000 | $0.00 | - | |
| Daniel Vitt - Officer | Grant or award | Stock Appreciation Right | 860,000 | $0.00 | - | |
 Andreas Muehler - Officer | Grant or award | Stock Appreciation Right | 330,000 | $0.00 | - | |
| Andreas Muehler - Officer | Grant or award | Stock Appreciation Right | 660,000 | $0.00 | - | |
| Andreas Muehler - Officer | Grant or award | Stock Appreciation Right | 660,000 | $0.00 | - | |
| Andreas Muehler - Officer | Grant or award | Stock Appreciation Right | 330,000 | $0.00 | - | |
| Andreas Muehler - Officer | Grant or award | Stock Appreciation Right | 330,000 | $0.00 | - | |
| Jason Tardio - Officer | Grant or award | Stock Appreciation Right | 330,000 | $0.00 | - | |
| Jason Tardio - Officer | Grant or award | Stock Appreciation Right | 660,000 | $0.00 | - | |
| Jason Tardio - Officer | Grant or award | Stock Appreciation Right | 660,000 | $0.00 | - | |
| Jason Tardio - Officer | Grant or award | Stock Appreciation Right | 330,000 | $0.00 | - | |
| Jason Tardio - Officer | Grant or award | Stock Appreciation Right | 330,000 | $0.00 | - | |
| Daniel Vitt - Officer | Open-market purchase | Common Stock | 15,000 | $0.77 | $12K | |
| Daniel Vitt - Officer | Grant or award | Stock Option | 1,558,000 | $0.00 | - | |
| Duane Nash - Officer | Open-market purchase | Common Stock | 20,000 | $0.83 | $17K | |
| Joerg Neermann - Director | Open-market purchase | Common Stock | 70,000 | $0.77 | $54K | |
| Joerg Neermann - Director | Open-market purchase | Common Stock | 30,000 | $0.76 | $23K | |
| Simona Skerjanec - Director | Grant or award | Stock Option | 150,000 | $0.00 | - | |
| Richard Alan Rudick - Director | Grant or award | Stock Option | 150,000 | $0.00 | - | |
Item 5.02, 9.01
Item 7.01, 9.01
Item 2.02, 5.02, 7.01, 9.01
Item 7.01, 9.01
IMUX insider trading FAQ
What is the latest insider trade for IMUX?
IMMUNIC, INC. (IMUX) had 3 insider filings in the last 90 days, with the most recent on 2026-09-19. The full record for IMUX runs to 46 Form 4 filings, the earliest from 2024-11-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMUX stock?
No insider purchases of IMUX were filed in the last 90 days. 8 purchases are on record for this company.
How many insiders are selling IMUX stock?
No insider sales of IMUX were filed in the last 90 days.
Where can I see IMUX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMUX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Robert Thorvald Nagel view on EDGAR
- - BVF PARTNERS L P view on EDGAR
- - Elena Ridloff view on EDGAR
- - Simona Skerjanec view on EDGAR
- - Richard Alan Rudick view on EDGAR
- - Barclay A. Phillips view on EDGAR
- - Joerg Neermann view on EDGAR
- - Jon Congleton view on EDGAR
- - Jon Congleton view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where IMUX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMUX with a 7-day demo
- IMUX on your watchlist
- Every IMUX Form 4 filing on record
- Up to 3 months of IMUX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
